Klerimed (Clarithromycin)

Clarithromycin works by binding to the bacterial 50S ribosomal subunit, inhibiting protein synthesis. This blockade prevents the formation of essential proteins needed for bacterial growth, leading to a bacteriostatic effect at lower concentrations and a bactericidal effect when drug levels are high enough.

The appropriate dose of Klerimed is determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and any concomitant medications. Dosage regimens are individualized and should follow the prescriber’s instructions.

Clarithromycin’s pregnancy category is listed as unknown, meaning safety data are limited. It should only be used during pregnancy or lactation when the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Klerimed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both clarithromycin and azithromycin belong to the macrolide class and share similar antibacterial spectra, but clarithromycin generally has a higher affinity for the 50S ribosomal subunit and a longer half‑life, allowing twice‑daily dosing. Azithromycin often requires once‑daily dosing and may have fewer drug‑interaction concerns due to weaker CYP3A4 inhibition.

Klerimed should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments to maintain stability.

Klerimed is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal upset. The exact administration schedule should follow the prescriber’s directions.

Serious risks include severe allergic reactions such as anaphylaxis, QT interval prolongation that can lead to arrhythmias, hepatotoxicity with elevated liver enzymes, Clostridioides difficile‑associated colitis, and rare skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash, chest pain, palpitations, or persistent vomiting.

Klerimed should not be used by individuals with a known hypersensitivity to clarithromycin, other macrolides, or any of the product’s excipients. It is also contraindicated in patients with a history of significant QT prolongation, ventricular arrhythmias, or those taking medications that strongly inhibit CYP3A4 without appropriate monitoring.